SCHEMBL1498331

SCHEMBL1498331

CC1(S(=O)(=O)c2cccc(C(F)(F)F)c2)CCN(C(Cl)C=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.40
▸ PKLR P30613 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RORC P51449 2/20 0.37
▸ CACNA1B Q00975 3/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ KDM2B Q8NHM5 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28799513 0.86 GAA (0.38) PKMPKLRHTTSMN1; SMN2CA1
SCHEMBL12692910 0.82 HTT (0.45) PKMPKLRHTTSMN1; SMN2CA1
SCHEMBL28799511 0.79 CACNA1B (0.41) SMN1; SMN2CA1CA2MMP1MMP2
SCHEMBL12543066 0.79 CNR1 (0.43) HTTSMN1; SMN2LMNAGAAHPGD
SCHEMBL10476060 0.78 CTSS (0.46) PKMPKLRHTTSMN1; SMN2CA1
SCHEMBL12688354 0.76 CA1 (0.47) HTTCA1CA2MMP1MMP2
SCHEMBL1498300 0.76 CA1 (0.47) PKMPKLRHTTCA1CA2
SCHEMBL1498307 0.76 RORC (0.50) PKLRHTTSMN1; SMN2CA1CA2
Hydrochloric Acid SCHEMBL1498397 0.75 CA1 (0.46) HTTCA1CA2MMP1MMP2
SCHEMBL28133670 0.75 MMP2 (0.46) PKMPKLRHTTCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2477963-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Zalicus Pharmaceuticals Ltd. (CA) 2012-07-25 — — EP disclosed
WO-2011035159-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS ZALICUS PHARMACEUTICALS LTD. (CA) 2011-03-24 — — WO disclosed
Send feedback